Novel CD20 monoclonal antibodies for lymphoma therapy
S Cang, N Mukhi, K Wang, D Liu - Journal of hematology & oncology, 2012 - Springer
Rituximab (RTX), a monoclonal antibody (mAb) against CD20, has been widely used for
lymphoma therapy. RTX in combination with cyclophosphamide/doxorubicin/vincristine …
lymphoma therapy. RTX in combination with cyclophosphamide/doxorubicin/vincristine …
Gastrointestinal lymphoma: the new mimic
AS Thomas, M Schwartz… - BMJ Open …, 2019 - bmjopengastro.bmj.com
Background Gastrointestinal (GI) lymphomas comprise a group of distinct clinicopathological
entities of B-or T-cell type, with primary gastrointestinal Hodgkin lymphoma being extremely …
entities of B-or T-cell type, with primary gastrointestinal Hodgkin lymphoma being extremely …
Primary lymphomas in the gastrointestinal tract
JC Peng, L Zhong, ZH Ran - Journal of digestive diseases, 2015 - Wiley Online Library
Primary gastrointestinal (GI) lymphomas are uncommon diseases that can involve the whole
GI tract. The etiologies of the disease remain unclear, and potential risk factors include …
GI tract. The etiologies of the disease remain unclear, and potential risk factors include …
Modern Treatment Delivery of Radiotherapy for Lymphomas and Leukemias: Making Every Gy Count
CG Patel, P Loap, YM Kirova - Seminars in Radiation Oncology, 2025 - Elsevier
Radiotherapy has a long history in the treatment of lymphoma and leukemia, in which late
toxicity outcomes have motivated current goals to improve how radiotherapy is delivered …
toxicity outcomes have motivated current goals to improve how radiotherapy is delivered …
Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study
CS Lewis, G Joy, P Jensen… - British Journal of …, 2024 - Wiley Online Library
Primary gastric diffuse large B‐cell lymphoma (PG‐DLBCL) accounts for the majority of extra‐
nodal DLBCL. Even so, literature is lacking on early, localised presentations. We studied a …
nodal DLBCL. Even so, literature is lacking on early, localised presentations. We studied a …
[PDF][PDF] Evaluation of parameters with potential prognosis impact in patients with primary gastric diffuse large B-cell lymphoma (PG-DLBCL)
I Rotaru, GD Găman, C Stănescu, AM Găman - Rom J Morphol Embryol, 2014 - rjme.ro
Background: Primary gastric lymphoma is the most common malignancy of the stomach after
gastric adenocarcinoma. Most cases are represented by the aggressive histological type …
gastric adenocarcinoma. Most cases are represented by the aggressive histological type …
Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma
H Ding, X Jin, N Ding, Z Fu, Y Song, J Zhu - Cancer Cell International, 2013 - Springer
Background R-CHOP has significantly improved survival rates of patients with diffuse large
B cell lymphoma (DLBCL) by~ 20% as compared to CHOP. CD20 antigen, highly expressed …
B cell lymphoma (DLBCL) by~ 20% as compared to CHOP. CD20 antigen, highly expressed …
Synchronous diffuse large B-cell lymphoma of the stomach and small cell lung carcinoma: A case report
J Li, C Zhou, W Liu, X Sun, X Meng - Medicine, 2017 - journals.lww.com
Interventions: As the patient received CHOP chemotherapy, pulmonary function deterioraed.
Etoposide was added to the chemotherapy. Outcomes: However, after the first treatment …
Etoposide was added to the chemotherapy. Outcomes: However, after the first treatment …
[HTML][HTML] 原发性胃恶性淋巴瘤患者的临床特点及预后危险因素分析
郑鹏， 韩从辉， 张亮， 仲永 - Advances in Clinical Medicine, 2021 - hanspub.org
目的: 分析原发性胃恶性淋巴瘤(PGL) 的临床特征, 治疗方法的选择及影响预后的因素. 方法:
回顾性分析徐州市中心医院2012 年11 月至2020 年11 月收治的72 例PGIL 患者的临床资料 …
回顾性分析徐州市中心医院2012 年11 月至2020 年11 月收治的72 例PGIL 患者的临床资料 …